Market Cap

Hangzhou Tigermed Consulting Co. Ltd Market Capitalization:

CN¥50.95 Billion

CNY as of Jan. 1, 2026

US$7.26 Billion

Hangzhou Tigermed Consulting Co. Ltd Company Profile

Hangzhou Tigermed Consulting Co. Ltd Main Stock Listing

SZSE: 300347

Market Capitalization History of Hangzhou Tigermed Consulting Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research

Company	Market Cap (USD)
Thermo Fisher Scientific	$222.61 B
Danaher	$164.98 B
Siemens Healthineers AG	$57.84 B
IDEXX Laboratories, Inc.	$53.62 B
Lonza Group Ltd	$47.58 B

Sector: Healthcare

Company	Market Cap (USD)
Lilly	$968.50 B
Johnson & Johnson	$499.57 B
AbbVie	$405.28 B
Roche	$332.12 B
UnitedHealth Group	$304.72 B

Yearly evolution of Hangzhou Tigermed Consulting Co. Ltd market cap

Date	Market Cap	YoY Change
Jan. 1, 2026	CN¥50.95 B	2.35%
Jan. 1, 2025	CN¥49.78 B	16.96%
Jan. 1, 2024	CN¥42.56 B	-53.99%
Jan. 1, 2023	CN¥92.50 B	6.07%
Jan. 1, 2022	CN¥87.20 B	-38.31%
Jan. 1, 2021	CN¥141.35 B	128.36%
Jan. 1, 2020	CN¥61.90 B	152.76%
Jan. 1, 2019	CN¥24.49 B	14.72%
Jan. 1, 2018	CN¥21.35 B	59.53%
Jan. 1, 2017	CN¥13.38 B	-6.34%
Jan. 1, 2016	CN¥14.29 B	31.74%
Jan. 1, 2015	CN¥10.85 B	16.78%
Jan. 1, 2014	CN¥9.29 B	126.54%
Jan. 1, 2013	CN¥4.10 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Hangzhou Tigermed Consulting Co. Ltd Categories

China Healthcare Diagnostics & Research

China Healthcare

China Diagnostics & Research

Stocks & Indices

Hangzhou Tigermed Consulting Co. Ltd has the following listings and related stock indices.

Stock: SZSE: 300347

Stock: FSX: 5HZ1

Stock: HKEX: 3347

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.